Cold Spring Harbor Laboratory  
Contact Us | Faculty & Staff Directory

Harbor Transcript


Contact Public Affairs

We want to hear from you.
Contact Us

Follow us on

  facebook-icon twitter-icon instagram-icon3 youtube-icon 

  wordpress-icon2 rss-icon email-icon linkedin-icon


candidate drug BI 7273
A collaborative effort by cancer researchers at Cold Spring Harbor Laboratory (CSHL) and chemists at Boehringer Ingelheim (BI), a pharmaceutical firm, has resulted in the identification of a new drug target in leukemia and creation of a candidate drug that hits the target. Perhaps even more important, the research demonstrates a new, highly accurate way of proving how this and certain other classes of drugs work -- extremely valuable information in the risky business of drug development. Read more

CSHL in the News

Genome Web
CSHL genome engineering meeting shows maturing CRISPR technologies
August 22, 2016

MIT Technology Review
New brain-mapping technique captures every connection between neurons
August 18, 2016

Chemistry World
Chemistry preprint server plan generates sparks
August 15, 2016

TBR Newsmedia
CSHL's Fan finds clue in the way ovarian cancer spreads
August 2, 2016...


  Latest News